Management of the neck in the setting of definitive chemoradiation: Is there a consensus? A GETTEC study

Annals of Surgical Oncology

Volumn 19, Issue 7, 2012, Pages 2311-2319

  Thariat, Juliette ^a   Hamoir, Marc ^b   Garrel, Renaud ^c   Cosmidis, Alain ^d   Dassonville, Olivier ^e   Janot, ^f   Righini, C A ^g   Vedrine, P O ^h   Prades, J M ⁱ   Lacau Saint Guily, J ^j   Jegoux, F ^k   Malard, O ^l   De Mones, E ^m   Benlyazid, A ⁿ   Bensadoun, R J ^o   Baujat, B ^j,l   Merol, J C ^p   Ferron, C ^l   Scavennec, C ^q   Salvan, D ^r   Mallet, Y ^s   Moriniere, S ^t   Vergez, S ^u   Choussy, O ^v   Dollivet, G ^w   Guevara, N ^x   Ceruse, P ^d   De Raucourt, D ^y   Lallemant, B ^z   Lawson, G ^aa   Lindas, P ^ab   Poupart, M ^d   Duflo, S ^ac   Dufour, Xavier ^o   more..

^a CENTRE ANTOINE LACASSAGNE   (France)

^b CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^c MONTPELLIER UNIVERSITY HOSPITAL   (France)

^d HOSPICES CIVILS DE LYON   (France)

^e CAL   (France)

^f INSTITUT GUSTAVE ROUSSY   (France)

^g GRENOBLE UNIVERSITY HOSPITAL   (France)

^h CH   (France)

ⁱ UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

^j Section of Radiology   (France)

^k RENNES UNIVERSITY HOSPITAL   (France)

^l NANTES UNIVERSITY HOSPITAL   (France)

^m BORDEAUX UNIVERSITY HOSPITAL   (France)

ⁿ INSTITUT CLAUDIUS REGAUD   (France)

^o POITIERS UNIVERSITY HOSPITAL   (France)

^p REIMS UNIVERSITY HOSPITAL   (France)

^q CH   (France)

^r CH   (France)

^s CENTRE OSCAR LAMBRET   (France)

^t UNIVERSITY HOSPITAL OF TOURS   (France)

^u TOULOUSE UNIVERSITY HOSPITAL   (France)

^v ROUEN UNIVERSITY HOSPITAL   (France)

^w UNIVERSITY HOSPITAL OF NANCY   (France)

^x UNIVERSITY HOSPITAL OF NICE   (France)

^y Centre Regional Francoise Baclesse   (France)

^z NÎMES UNIVERSITY HOSPITAL   (France)

^aa CHU   (Belgium)

^ab CH   (France)

^ac Centre Hospitalier Universitaire Pointe a Pitre   (Guadeloupe)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CETUXIMAB; DOCETAXEL; FLUORODEOXYGLUCOSE F 18; FLUOROURACIL;

ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; MAJOR CLINICAL STUDY; MINIMAL RESIDUAL DISEASE; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; QUESTIONNAIRE; TREATMENT RESPONSE; WART VIRUS;

CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; CONSENSUS; HEAD AND NECK NEOPLASMS; HUMANS; INDUCTION CHEMOTHERAPY; NECK DISSECTION; PHYSICIAN'S PRACTICE PATTERNS; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RADIOTHERAPY DOSAGE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84865138569     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-012-2275-9     Document Type: Article

References (64)

1. Ensley JF, Jacobs JR, Weaver A, et al. Correlation between response to cisplatinum-combination chemotherapy and subsequent radiotherapy in previously untreated patients with advanced squamous cell cancers of the head and neck. Cancer. 1984;54:811-4. (Pubitemid 14058432)
2. Peters LJ, Weber RS, Morrison WH, Byers RM, Garden AS, Goepfert H. Neck surgery in patients with primary oropharyngeal cancer treated by radiotherapy. Head Neck. 1996;18:552-9. (Pubitemid 26349535)
3. Brizel DM, Albers ME, Fisher SR, et al. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med. 1998;338: 1798-804. (Pubitemid 28277960)
4. Vedrine PO, Thariat J, Hitier M, et al.; French Groupe d'Etude des Tumeurs de la Tête et du Cou Group. Need for neck dissection after radiochemotherapy? A study of the French GETTEC Group. Laryngoscope. 2008;118:1775-80.
5. Liauw SL, Mancuso AA, Amdur RJ, et al. Postradiotherapy neck dissection for lymph node-positive head and neck cancer: the use of computed tomography to manage the neck. J Clin Oncol. 2006;24:1421-7. (Pubitemid 46622008)
6. Thariat J, et al. Prediction of neck dissection requirement after definitive radiotherapy for head and neck squamous cell carcinomas. Int J Radiat Oncol Biol Phys. 2012;82(3):e367-74.
7. Brizel DM, Prosnitz RG, Hunter S, et al. Necessity for adjuvant neck dissection in setting of concurrent chemoradiation for advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2004;58:1418-23. (Pubitemid 38438302)
8. Prades JM, Timoshenko AP, Schmitt TH, et al. Planned neck dissection before combined chemoradiation for pyriform sinus carcinoma. Acta Otolaryngol. 2008;128:324-8. (Pubitemid 351264427)
9. Thariat J, Marcy PY. Neck dissection and chemoradiation in head and neck cancer. Lancet Oncol. 2010;11:224-5.
10. Shoushtari A, Meeneghan M, Sheng K, et al. Intensity-modulated radiotherapy outcomes for oropharyngeal squamous cell carcinoma patients stratified by p16 status. Cancer. 2010;116:2645-54.
11. Kies MS, Holsinger FC, Lee JJ, et al. Induction chemotherapy and cetuximab for locally advanced squamous cell carcinoma of the head and neck: results from a phase II prospective trial. J Clin Oncol. 2010;28:8-14.
12. Yao M, Smith RB, Hoffman HT, et al. Clinical significance of postradiotherapy 18F-fluorodeoxyglucose positron emission tomography imaging in management of head-and-neck cancer-a long-term outcome report. Int J Radiat Oncol Biol Phys. 2009; 74:9-14.
13. Wee JT, Anderson BO, Corry J, et al.; Asian Oncology Summit. Management of the neck after chemoradiotherapy for head and neck cancers in Asia: consensus statement from the Asian Oncology Summit 2009. Lancet Oncol. 2009;10:1086-92.
14. Malone J, Robbins KT. Neck dissection after chemoradiation for carcinoma of the upper aerodigestive tract: indications and complications. Curr Opin Otolaryngol Head Neck Surg. 2010;18:89-94.
15. Ferlito A, Corry J, Silver CE, Shaha AR, Thomas Robbins K, Rinaldo A. Planned neck dissection for patients with complete response to chemoradiotherapy: a concept approaching obsolescence. Head Neck. 2010;32:253-61.
16. Thariat J, Hamoir M, Janot F, et al. Neck dissection following chemoradiation for node positive head and neck carcinomas. Cancer Radiother. 2009;13:758-70.
17. Hamoir M, Ferlito A, Schmitz S, et al. The role of neck dissection in the setting of chemoradiation therapy for head and neck squamous cell carcinoma with advanced neck disease. Oral Oncol. 2011. doi:10.1016/j.oraloncology.2011. 10.015.
18. van der Putten L, van den Broek GB, de Bree R, et al. Effectiveness of salvage selective and modified radical neck dissection for regional pathologic lymphadenopathy after chemoradiation. Head Neck. 2009;31:593-603.
19. Machtay M, Moughan J, Trotti A, et al. Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. J Clin Oncol. 2008;26:3582-9.
20. Lango MN, Egleston B, Ende K, et al. Impact of neck dissection on long-term feeding tube dependence in patients with head and neck cancer treated with primary radiation or chemoradiation. Head Neck. 2010;32:341-7.
21. McHam SA, Adelstein DJ, Rybicki LA, et al. Who merits a neck dissection after definitive chemoradiotherapy for N2-N3 squa-mous cell head and neck cancer? Head Neck. 2003;25:791-8. (Pubitemid 37139891)
22. Lango MN, Andrews GA, Ahmad S, et al. Postradiotherapy neck dissection for head and neck squamous cell carcinoma: pattern of pathologic residual carcinoma and prognosis. Head Neck. 2009; 31:328-37.
23. Narayan K, Crane CH, Kleid S, Hughes PG, Peters LJ. Planned neck dissection as an adjunct to the management of patients with advanced neck disease treated with definitive radiotherapy: for some or for all? Head Neck. 1999;21:606-13. (Pubitemid 29459865)
24. Stenson KM, Huo D, Blair E, et al. Planned post-chemoradiation neck dissection: significance of radiation dose. Laryngoscope. 2006;116:33-6. (Pubitemid 44383957)
25. Newman JP, Terris DJ, Pinto HA, Fee WE Jr, Goode RL, Goffinet DR. Surgical morbidity of neck dissection after che-moradiotherapy in advanced head and neck cancer. Ann Otol Rhinol Laryngol. 1997;106:117-22. (Pubitemid 27084003)
26. Lavertu P, Adelstein DJ, Saxton JP, et al. Management of the neck in a randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer. Head Neck. 1997;19:559-66. (Pubitemid 27407309)
27. Goguen LA, Chapuy CI, Li Y, Zhao SD, Annino DJ. Neck dissection after chemoradiotherapy: timing and complications. Arch Otolaryngol Head Neck Surg. 2010;136:1071-7.
28. Yao M, Hoffman HT, Chang K, et al. Is planned neck dissection necessary for head and neck cancer after intensity-modulated radiotherapy? Int J Radiat Oncol Biol Phys. 2007;68:707-13. (Pubitemid 46818743)
29. Jones AS, Tandon S, Helliwell TR, Husband DJ, Jones TM. Survival of patients with neck recurrence following radical neck dissection: utility of a second neck dissection? Head Neck. 2008;30:1514-22.
30. Duprez F, Bonte K, De Neve W, Boterberg T, De Gersem W, Madani I. Regional relapse after intensity-modulated radiotherapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys. 79:450-8.
31. Sabatini PR, Ducic Y. Planned neck dissection following primary chemoradiation for advanced-stage head and neck cancer. Oto-laryngol Head Neck Surg. 2009;141:474-7.
32. Gourin CG, Boyce BJ, Williams HT, Herdman AV, Bilodeau PA, Coleman TA. Revisiting the role of positron-emission tomography/computed tomography in determining the need for planned neck dissection following chemoradiation for advanced head and neck cancer. Laryngoscope. 2009;119:2150-5.
33. Nouraei SA, Upile T, Al-Yaghchi C, et al. Role of planned postchemoradiotherapy selective neck dissection in the multim-odality management of head and neck cancer. Laryngoscope. 2008;118:797-803. (Pubitemid 351631295)
34. Mukhija V, Gupta S, Jacobson AS, Eloy JA, Genden EM. Selective neck dissection following adjuvant therapy for advanced head and neck cancer. Head Neck. 2009;31:183-8.
35. Ganly I, Bocker J, Carlson DL, et al. Viable tumor in post-chemoradiation neck dissection specimens as an indicator of poor outcome. Head Neck. 2011;33:1387-93.
36. Clavel S, Charron MP, Bélair M, et al. The role of computed tomography in the management of the neck after chemoradio-therapy in patients with head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2012;82:567-73.
37. Bremke M, Barth PJ, Sesterhenn AM, Budach V, Engenhart-Cabillic R, Werner JA. Prospective study on neck dissection after primary chemoradiation therapy in stage IV pharyngeal cancer. Anticancer Res. 2009;29:2645-53.
38. Simon C, Goepfert H, Rosenthal DI, et al. Presence of malignant tumor cells in persistent neck disease after radiotherapy for advanced squamous cell carcinoma of the oropharynx is associated with poor survival. Eur Arch Otorhinolaryngol. 2006;263:313-8. (Pubitemid 43978739)
39. Clayman GL, Johnson CJ 2nd, Morrison W, Ginsberg L, Lipp-man SM. The role of neck dissection after chemoradiotherapy for oropharyngeal cancer with advanced nodal disease. Arch Oto-laryngol Head Neck Surg. 2001;127:135-9. (Pubitemid 32163638)
40. Cannady SB, Lee WT, Scharpf J, et al. Extent of neck dissection required after concurrent chemoradiation for stage IV head and neck squamous cell carcinoma. Head Neck. 2010;32:348-56.
41. Koch WM, Ridge JA, Forastiere A, Manola J. Comparison of clinical and pathological staging in head and neck squamous cell carcinoma: results from Intergroup Study ECOG 4393/RTOG 9614. Arch Otolaryngol Head Neck Surg. 2009;135:851-8.
42. Robbins KT, Doweck I, Samant S, Vieira F. Effectiveness of superselective and selective neck dissection for advanced nodal metastases after chemoradiation. Arch Otolaryngol Head Neck Surg. 2005;131:965-9. (Pubitemid 41696390)
43. Ahlberg A, Lagerlund M, Lewin F, Friesland S, Lundgren J. Clinical outcome following radiotherapy and planned neck dissection in N ? head and neck cancer patients. Acta Otolaryngol. 2008;128:1-7.
44. Byers RM, Clayman GL, Guillamondequi OM, Peters LJ, Goe-pfert H. Resection of advanced cervical metastasis prior to definitive radiotherapy for primary squamous carcinomas of the upper aerodigestive tract. Head Neck. 1992;14:133-8.
45. Hillel AT, Fakhry C, Pai SI, et al. Selective versus comprehensive neck dissection after chemoradiation for advanced oropharyngeal squamous cell carcinoma. Otolaryngol Head Neck Surg. 2009;141:737-42.
46. Dhiwakar M, Robbins KT, Vieira F, Rao K, Malone J. Selective neck dissection as an early salvage intervention for clinically persistent nodal disease following chemoradiation. Head Neck. 2012;34:188-93.
47. Hamoir M, Leemans CR, Dolivet G, Schmitz S, Grégoire V, Andry G. Selective neck dissection in the management of the neck after (chemo)radiotherapy for advanced head and neck cancer. Proposal for a classification update. Head Neck. 2010;32: 816-9.
48. Rogers JW, Greven KM, McGuirt WF, et al. Can post-RT neck dissection be omitted for patients with head-and-neck cancer who have a negative PET scan after definitive radiation therapy? Int J Radiat Oncol Biol Phys. 2004;58:694-7. (Pubitemid 38221123)
49. Argiris A, Stenson KM, Brockstein BE, et al. Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer. Head Neck. 2004;26:447-55. (Pubitemid 38569204)
50. Corry J, Peters L, Fisher R, et al. N2-N3 neck nodal control without planned neck dissection for clinical/radiologic complete responders-results of Trans Tasman Radiation Oncology Group Study 98.02. Head Neck. 2008;30:737-42. (Pubitemid 351913849)
51. Waldron JN, et al. Results of an Ontario Clinical Oncology Group (OCOG) prospective cohort study on the use of FDG PET/CT to predict the need for neck dissection following radiation therapy of head and neck cancer (HNC) (abstract). J Clin Oncol. 2011; 29:5504.
52. Nayak JV, Walvekar RR, Andrade RS, et al. Deferring planned neck dissection following chemoradiation for stage IV head and neck cancer: the utility of PET-CT. Laryngoscope. 2007;117:2129-34. (Pubitemid 351339585)
53. Porceddu SV, Jarmolowski E, Hicks RJ, et al. Utility of positron emission tomography for the detection of disease in residual neck nodes after (chemo)radiotherapy in head and neck cancer. Head Neck. 2005;27:175-81. (Pubitemid 40315765)
54. Yao M, Graham MM, Hoffman HT, et al. The role of postradiation therapy FDG PET in prediction of necessity for postradiation therapy neck dissection in locally advanced head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 2004;59:1001-10. (Pubitemid 38834292)
55. Schöder H, Fury M, Lee N, Kraus D. PET monitoring of therapy response in head and neck squamous cell carcinoma. J Nucl Med. 2009;50(Suppl 1):74S-88S.
56. Lyford-Pike S, Ha PK, Jacene HA, Saunders JR, Tufano RP. Limitations of PET/CT in determining need for neck dissection after primary chemoradiation for advanced head and neck squa-mous cell carcinoma. ORL J Otorhinolaryngol Relat Spec. 2009; 71:251-6.
57. Rengan R, Pfister DG, Lee NY, et al. Long-term neck control rates after complete response to chemoradiation in patients with advanced head and neck cancer. Am J Clin Oncol. 2008;31: 465-9.
58. Grimard L, Esche B, Lamothe A, Cygler J, Spaans J. Interstitial low-dose-rate brachytherapy in the treatment of recurrent head and neck malignancies. Head Neck. 2006;28:888-95. (Pubitemid 44497864)
59. Goldenberg D, Begum S, Westra WH, et al. Cystic lymph node metastasis in patients with head and neck cancer: an HPV-asso-ciated phenomenon. Head Neck. 2008;30:898-903. (Pubitemid 352008950)
60. Fakhry C, Westra WH, Li S, et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst. 2008;100:261-9. (Pubitemid 351480538)
61. Marandas P, Germain MA, Casiraghi O, et al. Cervical cystic lymph-node metastases from epidermoid carcinoma. Bull Acad Natl Med. 2003;187:1117-27.
62. Haerle SK, Strobel K, Ahmad N, Soltermann A, Schmid DT, Stoeckli SJ. Contrast-enhanced (18) F-FDG-PET/CT for the assessment of necrotic lymph node metastases. Head Neck. 2011;33:324-9.
63. Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010;363:24-35.
64. Shonka DC Jr, Shoushtari AN, Thomas CY, et al. Predicting residual neck disease in patients with oropharyngeal squamous cell carcinoma treated with radiation therapy: utility of p16 status. Arch Otolaryngol Head Neck Surg. 2009;135:1126-32.